Literature DB >> 11122845

Preventing relapse in melanoma.

J Stebbing1, M Gore.   

Abstract

Entities:  

Mesh：

Year:  2000        PMID： 11122845     DOI： 10.1007/s11912-000-0068-y

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN： 1523-3790            Impact factor:   5.075


× No keyword cloud information.
  34 in total

Review 1.  Gene transfer by adenovectors.

Authors:  M Brenner
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

2.  Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

Authors:  S K Nair; D Boczkowski; M Morse; R I Cumming; H K Lyerly; E Gilboa
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

Review 3.  Different approaches in the gene therapy of cancer.

Authors:  M J Gough; R G Vile
Journal:  Forum (Genova)       Date:  1999 Jul-Sep

4.  Adjuvant immunotherapy or chemotherapy for malignant melanoma. Preliminary report of the National Cancer Institute randomized clinical trial.

Authors:  R I Fisher; W D Terry; R J Hodes; S A Rosenberg; R Makuch; H G Gordon; S G Fisher
Journal:  Surg Clin North Am       Date:  1981-12       Impact factor: 2.741

5.  Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma.

Authors:  K Palmer; J Moore; M Everard; J D Harris; S Rodgers; R C Rees; A K Murray; R Mascari; J Kirkwood; P G Riches; C Fisher; J M Thomas; M Harries; S R Johnston; M K Collins; M E Gore
Journal:  Hum Gene Ther       Date:  1999-05-20       Impact factor: 5.695

6.  Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

Authors:  U Keilholz; C Conradt; S S Legha; D Khayat; C Scheibenbogen; N Thatcher; S H Goey; M Gore; T Dorval; B Hancock; C J Punt; R Dummer; M F Avril; E B Bröcker; A Benhammouda; A M Eggermont; M Pritsch
Journal:  J Clin Oncol       Date:  1998-09       Impact factor: 44.544

7.  Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

Authors:  R B Cameron; J K McIntosh; S A Rosenberg
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

8.  Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.

Authors:  W B Hamilton; F Helling; K O Lloyd; P O Livingston
Journal:  Int J Cancer       Date:  1993-02-20       Impact factor: 7.396

9.  Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma.

Authors:  B Thurner; I Haendle; C Röder; D Dieckmann; P Keikavoussi; H Jonuleit; A Bender; C Maczek; D Schreiner; P von den Driesch; E B Bröcker; R M Steinman; A Enk; E Kämpgen; G Schuler
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  Vaccination with IL-7 gene-modified autologous melanoma cells can enhance the anti-melanoma lytic activity in peripheral blood of patients with a good clinical performance status: a clinical phase I study.

Authors:  P Möller; Y Sun; T Dorbic; S Alijagic; A Makki; K Jurgovsky; M Schroff; B M Henz; B Wittig; D Schadendorf
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.